Caris Life Sciences Inc
NASDAQ:CAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
T
|
TROOPS Inc
F:SG5
|
KY |
|
Northern Trust Corp
NASDAQ:NTRS
|
US |
|
Transcontinental Inc
F:53L
|
CA |
Intrinsic Value
Is CAI undervalued or overvalued?
See the intrinsic value estimate for Caris Life Sciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CAI looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CAI’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Caris Life Sciences Does
Caris Life Sciences is a precision medicine company focused on cancer. It analyzes tumor tissue and blood to read a patient’s molecular and genetic signals, then turns that information into reports that help doctors choose and monitor treatment. Its main products are advanced laboratory tests and the data generated from them, especially in oncology.
- Headquarters
- United States of America US
- Employees
- 1 846
- IPO date
- Jun 18, 2025
Earnings Waterfall
Caris Life Sciences Inc
The intrinsic value for Caris Life Sciences Inc (CAI) under the Base Case is hidden USD.
Compared with the current market price of 32.455 USD, the stock appears hidden.